Exubera Inhaled Insulin Gets Favorable Committee Review In Europe

European Medicines Agency's Committee for Medicinal Products for Human Use recommends approval of Pfizer/Sanofi's agent for type 1 and 2 diabetes with post-market monitoring for pulmonary function decline and hypoglycemia.